TGTX Earnings Tg Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.12 | 2026-05-06 | 10-Q |
| FY 2025 | 2025-12-31 | 2.77 | 2026-02-27 | 10-K |
| Q3 2025 | 2025-09-30 | 2.62 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.20 | 2025-08-08 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.03 | 2026-05-06 | 10-Q |
| FY 2025 | 2024-12-31 | 0.15 | 2026-02-27 | 10-K |
| Q3 2025 | 2024-09-30 | 0.00 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.03 | 2025-08-08 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.07 | 2025-05-09 | 10-Q |
| FY 2025 | 2023-12-31 | 0.09 | 2026-02-27 | 10-K |
| Q3 2024 | 2023-09-30 | 0.19 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.62 | 2024-08-09 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.28 | 2023-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -1.65 | 2025-03-03 | 10-K |
| Q3 2023 | 2022-09-30 | -1.08 | 2023-11-06 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.81 | 2023-08-04 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.51 | 2023-05-08 | 10-Q |
| FY 2023 | 2021-12-31 | -2.63 | 2024-02-29 | 10-K |
| Q3 2022 | 2021-09-30 | -1.93 | 2022-11-09 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.28 | 2022-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.